Successive T-precursors isolated from adult mouse thymus were examined for their developmental potential, by transfer to irradiated Ly 5-disparate recipients. The earliest, "low CD4" precursors formed T, B, and dendritic cells (DC), but not myeloid cells, in accordance with earlier studies. Surprisingly, the next downstream CD4-8-3-44+25 + precursor population still formed DC as well as T cells although it no longer formed B or myeloid cells. Further downstream, the CD4-8-3-44-25 + population formed only T cells. The thymic and splenic DC progeny of the early thymic precursors all expressed high levels of CD8c~, in contrast with normal splenic DC and the splenic DC progeny of bone marrow stem cells, which consisted of both CD8-and CD8 + DC. A common precursor of T ceils and of a subclass of DC is proposed, with CD8c~ as a marker of the lymphoid-related DC lineage.
T
he earliest precursor ofT lymphocytes so far identified in the adult mouse thymus resembles bone marrow hematopoietic stem cells (BMSC) ~ in surface phenotype, except for the expression of the antigen Sca-2 and of a low level of CD4: for this reason we have termed it the "low CD4 precursor" (l-3). This population has TCR 13 and y genes in germline configuration. Despite the presence of some enzymes associated with recombination, it still lacks even D-J 13 gene rearrangements (1, 4) . A striking feature of this population is its ability to generate dendritic cells (DC), B, and NK cells, as well as T cells, although it has lost the capacity to generate erythroid and most myeloid cells (2, (5) (6) (7) (8) (9) . This suggested the same early intrathymic precursor cell gives rise to both thymic DC and to the thymic T-lineages (5, 6) , in contrast to the established myeloid origin for most DC (10, 11) . Strict clonal evidence for this hypothesis of a lymphoid origin for thymic DC is still not available. However, some support of the concept has come from the finding that thymic DC express several surface molecules normally considered characteristic of lymphoid cells, in particular the early B cell marker BP-1 (6) and the T cell marker CD8, in the form of an c~ homodimer (6, 12) .
Another early T-precursor cell was delineated by Godfrey and Zlotnik (13) and Godfrey et al. (14) within the CD4-8-3-(triple negative) population. This precursor is CD44 + c-kit +, like the low CD4 precursor, but as well as losing CD4 it has gained CD25 (IL-2II.c,) and shows some IAbbreviations used in this paper: BMSC, bone marrow stem cell; I)C, dendritic cell; Lin BM, lineage marker negative bone marrow cells.
upregulation of surface Thy-1. Like the low CD4 precursor, it has the C[3 (14) and the D-J [3 (4, 15) gene regions in germline state. For this reason it is termed a pro-T cell and it has been assumed to be downstream from the low CD4 precursor. This precursor population has been found to lack both B and NK cell developmental potential and accordingly has been assumed to be the point of T cell commitment (7, 9) .
Still further downstream is the "triple negative pre-T cell" (3, 13) , which has the surface phenotype CD4-8-3-CD44-25 + c-kit-Thy-1 + (although both CD44 and c-kit should be more precisely defined as low rather than negative). This precursor population represents the stage where TCR 13 genes are rearranged (4, 13, 15) , and on this basis would be considered a T-committed population. Exit from this stage and further development towards c~/]3 T cells involves signals from the newly described pre-T a chain (16) .
We now assess the ability of all three of these early T-lineage precursor populations to generate DC, and compare this to their capacity to produce other hemopoietic lineages. The results suggest a sequential rather than simultaneous loss of other developmental potentials en route to T cells, with the ability to fbrm DC only being lost at the stage of TCR 13 gene rearrangement. Since the artificial transfer of the low CD4 thymic precursor population by intravenous injection produced progeny DC in the spleen as well as in the thymus, we have been able to assess whether the unique surface phenotype of thymic DC is dictated by the enviromnent or by the nature of the precursor. Although some markers varied with the site of development, CD8o~ was always present and served as a marker of the DC lineage derived from the T cell precursors.
Materials and Methods
Mice. The mice were bred at The Walter and Eliza Hall Institute under specific pathogen-free conditions. The donors in reconstitution experiments were 4-6-wk-old C57BL/Ka Thy-1.1 fLy 5.2) or C57BL/6 (Thy-l.2, Ly 5.2) mice and the recipients were 7-8-wk-old C57BL/6 Ly 5.1-Pep 3b (Thy-1.2) mice.
mAbs and Fluorescent Reagents. The mAbs and hybridoma clones used for depletion and for immunofluorescent labeling, the fluorochromes employed, and the fluorescent reagents used, are all specified elsewhere (4, 6, 12) .
Purification ~f lntrathymic Precursor Populations. The low CD4
precursors were isolated from C57BL/Ka Thy-l.1 or C57BL/6 donor thynmses as described previously (1, 2, 5) . This involved complement-mediated cytotoxic depletion, adherence depletion, and then imnmnomagnetic bead depletion of mature thymocytes, of CD4+8 + thymocytes, of more developed precursors bearing CD2 or CD25, and of non T-lineage cells. The <1% remaining cells were then stained in three fluorescent colors and the low CD4 precursors (5-10% of the depleted population) sorted as Thy-P ~ heat-stable antigen (HSA) mt class II MHC-cells. Purity on reanalysis was 98-99%. In some experiments, an improved procedure (4) involving densi W separation, adherence, double immunomagnetic bead depletion, then sorting the precursors as Thy-11~ HSA in~ c-kit + cells, was also used with identical results.
The triple negative, CD44+25 + and CD44-25 + populations were isolated as described previously (4) . This involved cytotoxic and inmmnomagnetic bead depletion of cells bearing CD4, CD8, and CD3, together with depletion of non T-lineage cells. The depleted cells were then immunofluorescent stained and the precursors sorted on the basis of CD25 and c-kit expression. Purity on reanalysis for CD25, c-kit, and CD44 expression was 97-98%.
Pur!fication of BMSC. 
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Gr-1 Three separate experiments, one for each precursor population, are shown; each result was typical of three experiments. The quadrants were set based on the background staining for each experiment. The differences in staining intensity between experiments was due to changes in the reagents used and variations in instrument settings. Note that there is no staining for recipient type Thy-I + cell in the spleen and lymph nodes reconstituted by Lin BM. This is because in these particular experiments, the Lin-BM cells were obtained from C57BL/6 Ka Thy-l.1 (Ly 5.2) mice, and in the analysis for donor-derived cells, only anti-Thy-l.1 antibody was used together with anti-Ly 5.2 to reveal the donor type Thy-1 + cells but not the recipient type Thy-I + (Thy-l.2) cells. In the experiments with thynfic precursors, both donor and recipient were Thy-l.2 mice, and the anti-Thy-l.2 antibody revealed both donor and recipient T cells.
Results
Reconstitution Kinetics. To check that the various thymic T-precursor populations behaved as sequential steps in T cell development, the kinetics of development of T-lineage progeny after intrathymic and intravenous transfer into irradiated recipients differing in Ly 5 allotype, was compared ( Fig. 1) , using criteria previously established in this laboratory (18, 19) . Upon intrathymic transfer, the fastest reconstitution was obtained with the CD44-25 + triple negative pre-T precursor, the next fastest with the CD44+25 + triple negative pro-T precursor, and the slowest reconstitution from the low CD4 precursor (Fig. 1 ). This result is in line with the fetal thymus organ culture repopulation studies of Godfrey et al. (14) , assuming that their CD44+25 -population corresponds to our low CD4 precursors. Previously we had established that the low CD4 precursor, in turn, gave faster reconstitution than BMSC (1). Similar reconstitution kinetics were obtained after intravenous transfer (Fig. 1) , except that very few progeny were detected with the CD44-CD25 + precursor population. This population was deficient in its ability to seed the thymus, presumably because of its low expression of CD44, a thymus-homing molecule (20, 21) . In addition to this ki-netic evidence, we have previously demonstrated that after transfer, the progeny of the low CD4 precursors lose CD4 and gain CD25 (1, 2) . Accordingly, all these results support the earlier models (3, 13) of a linear, sequential developmental process with the precursors in the sequence: low CD4 precursor, then CD44+25 + pro-T, then CD44-25 + pre-T.
Development of Lymphoid and Myeloid Cells from Intrathymic Precursors.
To provide a side-by-side control for the DC precursor studies and to check previous conclusions, the nature of the predominant progeny formed in the spleen and lymph nodes of irradiated recipients after intravenous injection of the intrathymic precursors was determined. Suspensions of pooled recipient spleen and lymph nodes were stained for donor type Ly 5.2, together with anti-Thy-1 (for T cells), anti-B220 (for B cells), and anti-Mac-1 together with anti-Gr-1 (for myeloid cells). The results were compared with those obtained by transfer of bone marrow cells depleted of cells bearing markers of the hemopoietic lineages (Lin-BM), an enriched source of BMSC. Fig. 2 gives examples of the analysis. The low CD4 precursor formed not only T cell progeny but also B cell progeny, in agreement with our previous findings (2). As reported previously, these B220 + progeny were also surface Ig positive, and appeared to be typical small B cells (data not shown).
No discrete population ofmyeloid (Mac-1 + or Gr-l+) cells was obtained (Fig. 2 ), in accordance with our previous resuits. In contrast, the CD3-4-8-44+25 + pro-T precursors formed T cells but very few, if any, B cells, and the apparent yield of myeloid cells was within the range of the background levels. This lack of potential for B cell development by this triple negative precursor has already been reported by others, for both adult and fetal thymus (7, 9) . As expected, the later CD3-4-8-44-25 + pre-T population was also unable to form B or myeloid cells in the recipient spleens and lymph nodes (data not shown). As we have previously reported (2), at these time points Mac-l+/Gr-1 + B220 +, and Thy-1 + progeny were all readily detected and resolved as discrete populations, when a preparation enriched for BMSC (Lin-BM) was transferred, with B220 + B cells being the dominant progeny (Fig. 2) . If the numbers of cells found in the positive quadrants were compared, the ratio of donor-derived Thy-1 + T cells to donor-derived Mac-1 +/Gr-I + myeloid cells 4 wk after intravenous transfer was: Lin-BM, 0.6; low CD4 precursors, 66; and CD44+25 + precursors, 163. Thus, the thymic precursors were almost devoid of myeloid potential, an important issue when considering their DC developmental potential. 
Development of DC fiom Intrathymic Precursors. Having con-
firmed the sequential loss of myeloid and then B lymphocyte potential by these early T-precursor populations, we used the same procedures to assess DC developmental potential. In particular, since the CD44+25 + triple negative pro-T cell was confirmed to have lost the capacity to form B cells despite still being in germline configuration for the TCP, genes tested (4, 13, 15), its capacity to form DC in thymus and spleen was compared with that of the low CD4 precursor. Because DC are relatively rare components, it was necessary to pool recipient organs and enrich for DC before analysis. This enabled even low levels of DC to be detected above the background. Examples of the analysis of these enriched preparations for donor type (Ly 5.2 +) DC (class II MHC m) after intravenous transfer of precursors is given in Fig. 3 ; it is important to note that the results were similar when other markers of DC, including CDllc and DEC-205, were used instead or in combination with class II MHC. The total number of DC progeny obtained after transfer of different precursors is given in Table 1 .
As we have reported previously (5, 6), the low CD4 precursor population fomled DC in both the thymus and the spleen after intravenous transfer. In surprising contrast to the result for B cell progeny, the later CD44+25 + triple negative pro-T cells showed an undiminished capacity to form DC progeny in thymus and spleen, compared with the low CD4 precursors. However, although 10-fold more cells were transfered, the downstream CD44-25 + triple negative pre-T cells formed very few, if any, DC progeny regardless of the route of transfer (Table 1) . Thus, during early thymic precursor cell development, the capacity to form B cells was lost before the capacity to form DC.
Nature qf the DC Developing in the Thymus and in the Spleen from Thymic precursors.
To test whether the surface phenotype of thymic DC was determined by the thymic environment or by the nature of the DC precursor, the thymic precursors were transferred intravenously into irradiated recipients and the surface phenotype of the DC progeny in spleen and thymus determined. The DC progeny of the thymic precursors were compared with normal splenic and thymic DC. They were also compared with the DC generated by pure, long-term reconstituting BMSC, since these should generate all DC populations, and should indicate the type of DC likely to be produced if any multipotent stem cells contaminated the thymic precursor population.
In the first series of experiments, the level of Thy-I on the surface of the DC progeny was analyzed, since freshly isolated thymic DC have some surface Thy-1, whereas splenic DC have very little (12) . The progeny of thymic DC precursors showed some low surface Thy-1 staining in the thymus, but none in the spleen (data not shown). However, the reason for this proved to be trivial, as we have since demonstrated that most Thy-I on the surface of thymic DC is picked up from thymocytes, rather than being synthesized by the DC themselves (22) .
In the second series of experiments, the level of BP-1, a surface peptidase expressed on early B cells (23) , was investigated. Many thymic DC are BP-1 + and contain BP-1 mlq, NA, whereas splenic DC are surface BP-1-and lack BP-1 mRNA (6, 22) . The progeny of thymic low CD4 DC precursors in the spleen proved to be clearly BP-I-, like normal splenic DC, whereas the progeny in the thymus were BP-1 +, like normal thymic DC (Fig. 4) . The same was found for the DC progeny of BMSC (Fig. 4) . Accordingly, it appeared that BP-1 was induced on DC by the thymic environment, rather than being dictated by the precursor cell. In the third series of experiments, the level of CD8cx on the surface of the DC progeny was determined, since thymic DC are almost all CD8cC, whereas a definite population of splenic DC are CD8cx- (6, 12) . It has also been established that CD8ot + DC contain CD80~ mRNA (but not CD8~3 mRNA), so the CD8er is synthesized by the DC themselves (12) . The pure BMSC reconstituted both the CD8-and CD8 + DC populations of spleen, in a proportion almost identical to the normal splenic DC populations (Fig. 5) . In contrast, the thymic low CD4 precursor and the thymic CD44*CD25 + precursor both produced only CD8 + DC, in both the thymus and the spleen (Fig. 5) . Since the animals injected with the Ly 5.2 + thymic precursors were also injected with recipient type Ly 5.1 + bone marrow cells to ensure survival after irradiation, these experiments also had an internal control. In contrast to the Ly 5.2 + DC progeny of the thymic precursors, the Ly 5.1 + recipient type DC had the normal proportion of CD8-DC, exactly as for the BMSC reconstituted animals (data not shown).
A kinetic study of the DC progeny after intravenous transfer of different precursor populations was performed to ensure these results did not alter with time after reconstitution. It was found that 87% of splenic DC progeny of the low CD4 precursors were strongly CD8 + at day 17, 93% were CD8 + at day 2l, and 96% were CD8 + at day 28. At no time point was a discrete CDS-population obtained. Although a small proportion of DC expressing lower levels of CD8 was evident among the progeny, especially early after transfer, these were probably less mature cells in the process of acquiring CD8; we have already demonstrated that the level of CD8 on thymic DC increases with their maturation (6) . In comparison, the BMSC gave rise to 76% CD8 + splenic DC progeny at day 17, 78% at day 21, and 60% at day 28, with a discrete CD8-DC population being obtained at all time points.
Our procedure for DC isolation (12) normally includes a step of macrophage depletion, using graded levels of antiMac-1 and immunomagnetic beads, which removes cells expressing high levels of Mac-1 but leaves cells expressing low levels of Mac-1. We have recently noted that a higher proportion of CDS-DC can be extracted from spleen if Mac-1 depletion is avoided entirely during DC enrichment. Accordingly, the DC progeny of the thymic precursors were examined using this less stringent enrichment procedure (Fig. 6 ). Even though this increased the relative level of CDS-DC detected in normal spleen, no CDS-DC progeny, only CD8 + DC progeny, were obtained from the thymic precursors.
Discussion
Our kinetic studies on thymus reconstitution reinforce the view (1, 3, 13) that the low CD4 precursors represent the earliest T-precursor population so far defined ~lnd isolated from the adult mouse thymus. The rate of thymus reconstitution, as well as the surface phenotype, suggests these precursors are intermediate in development between BMSC and the pro-T CD4-8-3-44+25 + thymic subset. However, the relatively broad peak of reconstitution from the low CD4 precursors suggests that more than a single wave of reconstitution is involved. This precursor population may therefore include both very early cells and cells almost as mature as the CD44+25 + population. This fits with our concept that the low CD4 precursor population includes cells from some 7 d of development after the initial seeding event (3, 24) . This implies that the initial cells seeding from the bone marrow, and their immediate products, might still be minority components of this preparation. These still earlier precursors could even be multipotent, and responsible for the traces of myeloid precursor activity we sometimes see in the low CD4 precursor population. This trace of possible myeloid precursor activity has largely disappeared from the later, CD4 8-3-44+25 + pro-T population.
Even allowing for some heterogeneity in developmental state, the low CD4 early precursor population of the adult mouse thymus displayed some surprising developmental capabilities, apparently differing from those of the early precursor cells in embryonic mouse thymus (25) or blood (26) . The capacity to form both T and B cells, but very few erythrocytes, granulocytes, or macrophages (2), suggested the low CD4 precursor population might correspond to a "lymphoid-restricted precursor." Such a cell was not new in concept, even though evidence for its existence had been meagre. However, the capacity of the low CD4 precursor to form DC as well as lymphoid cells (5) was startling, since at least some types of DC have been found to be of myeloid origin (10, 11) and the low CD4 precursor showed little capacity to form other myeloid cells (2) . One possible explanation was that the low CD4 precursor population consisted of a group of separate unipotent precursors with similar surface antigenic phenotype, although it was then not clear why the thymus would accumulate a B-restricted precursor cell it would never use (2) .
The explanation that this early T precursor population only appeared to be oligopotent because it was "contaminated" with separate DC and B precursors, or with multipotent stem cells, now seems less likely, since the downstream c-kit + CD44+25 + pro-T cell also shows DC precursor activity. The procedure for the isolation of this CD44+25 + precursor population differs totally from that of the low CD4 precursor, and the level of possible myeloid precursor activity is still lower and now indistinguishable from the background. Yet this CD44+25 + precursor shows undiminished DC precursor activity per cell and shows a ratio of DC to T cell progeny similar to that of the low CD4 precursor population. Furthermore, the low CD4 precursor and the CD44+25 + precursor both produce only the CD8o~ type of DC, even when they seed the spleen, in contrast to BMSC; this is further evidence that they are not contaminated with multipotent stem cells or myeloid precursors. These results indicate there is a coincidence, or at least a very strong linkage, between the thymic DC precursors and the earliest T-lineage precursors. Of course the results with the CD44+25 + precursor do not strengthen the evidence for a common T and B cell precursor potential at the low CD4 precursor stage. However, in support of the view of a common DC/lymphoid precursor, a cell with T, B, and DC generative capacity, but apparently unable to form other lineages, has now been isolated from human bone marrow by Galy et al. (27) . Linked pathways ofT cell and DC development from human thymus CD34 + precursors have also been described by M~lrquez et al. (28) , although these precursors also had monocyte developmental potential. We favor the concept that the T, B, and DC progenitor activities are developmentally linked, having a common precursor downstream from the BMSC. Since the capacity to form B cells is lost before DC, thymic DC would then be a relatively late branch off the T lineage. This concept still requires direct confirmation, either by a clonal approach or by further evidence that DC bear markers of a lymphoid past.
It is of interest that the c-kit-CD44-25 + pre-T cell, the cell undergoing TCR [3 gene rearrangement (3, 13, 15) , lacks detectable B or DC precursor activity. By this stage this precursor seems fully committed to the T cell lineage, although the issue of ot/[~ versus ",//5 lineage commitment is still under debate. It is not clear whether TCt< gene rearrangement itself, or some linked control mechanism, determines this T-lineage commitment.
Ifthymic DC are a discrete DC lineage, either lymphoid derived or in some other way linked to T cell development, can this lineage be distinguished from other DC on the basis of surface markers? It is now clear that certain molecules on the surface of thymic DC are simply picked up from associated thymocytes and cannot serve as useful markers: Thy-1 is clearly in this category (6, 22) and it is likely that a small amount of CD4 and CDSot/[B can also be absorbed onto DC (6) . Nor do surface molecules made by the DC themselves in response to a particular inductive environment serve as useful permanent markers of a lineage. BP-1, although formed by thymic DC themselves (6), appears to be induced by the thymic environment, since in the spleen the progeny of thymic DC precursors are BP-1-. However, our evidence suggests that CD8oe expression does mark a distinct thymic type of DC lineage, since the thymic DC precursors formed only CD8cl + DC even when allowed to produce DC in the spleen. This was in contrast to BMSC that formed both CD8-and CD8 + DC in the spleen. To date, CD8a is the only marker present on thymic DC that is consistently associated with the progeny of the thymic precursors regardless of whether they develop in the spleen or the thynms.
If CD8o~ marks a lymphoid-derived or lymphoid-related thymic DC population, we must now question the origin of the CD8o~ + DC found in the spleen and other lymphoid tissues. To date, there is no evidence that the CD8 + and CD8-DC of spleen have a precursor-product relationship, although a few CD8-DC could be immature cells en route to CD8 + (6). On overnight incubation these CD8 + and CD8-DC retain their phenotype, the only change being some increase in the CD8oe expression by the CD8 + DC (6) . The CD8 + DC in spleen are unlikely to be thymus derived since they are present at normal levels in athynfic "nude" nmuse spleen (Vremec, D., and K. Shortman, unpublished data). We have been unable to detect the exit from the thymus of either the precursor cells or the DC progeny after intrathymic transfer (Wu, L., unpublished data). Our experiment of injecting the thymic precursors intravenously was therefore artificial, since there is no evidence that such precursors ever exit the thymus. Nevertheless this experiment suggests that an equivalent lymphoidderived or lymphoid-related precursor may exist outside the thymus and give rise to a line of splenic CD8ot + DC, separate from but related to thymic DC. An important issue is whether these proposed CD8 + and CD8-splenic DC lineages differ in biological function. Our recent studies indicate that they do differ in function. Although both CD8 § and CD8-DC are able to activate CD4 T cells, the Fas ligand-bearing CD8 § DC then kill these activated T cells by Fas-mediated apoptosis (29) . The CD8 § DC may therefore have a regulatory function distinct from the better known stimulatory CDS-DC.
